Saturday 17 October 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 157.1%, free cash flow fell 351.4% and total debt rose 8.22%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

19.18 0.07 −0.36%

Follow AMRX

Alert me

Market cap: $6.2B
P/E: 38.4×
Fwd P/E: 51.6×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	500.50	54.78	31.87	34.62
P/S ratio Full definition →		1.07	1.31	1.29	1.77
P/FCF ratio Full definition →		13.22	17.34	20.71	0.00
P/Operating CF Full definition →		26.55	30.30	(146.89)	(260.09)
P/B ratio Full definition →		0.00	0.00	0.00	167.31
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		1.87	2.06	2.09	2.59
EV/EBITDA Full definition →		8.79	9.70	9.60	12.12
EV/Operating CF Full definition →		16.73	18.26	20.77	40.14
EV/FCF Full definition →		23.05	27.27	33.50	(695.25)
Quick Ratio Full definition →		1.30	1.37	1.45	1.31
Current Ratio Full definition →		2.13	2.17	2.47	2.20
Net Debt/EBITDA Full definition →		18.06	13.71	12.84	13.95
Debt/Assets Full definition →		71.49%	69.92%	74.19%	70.71%
Debt/Equity Full definition →		(23.41)	(36.06)	(57.14)	80.86
Asset Turnover Full definition →		0.83	0.84	0.88	0.87
Operating CF/Net income Full definition →		50.00	3.72	(0.43)	(0.37)
Capex/Depreciation Full definition →		(0.38)	(0.86)	(0.46)	(2.37)
Interest Coverage Full definition →		1.12	1.99	2.66	2.36
Research and Development Expense of Revenue Full definition →		8.08%	4.28%	5.31%	4.90%
Selling, General and Administrative Expense of Revenue Full definition →		17.57%	17.99%	19.22%	18.68%
Intangible Assets out of Total Assets Full definition →		0.33	0.32	0.32	0.31
Share Based Compensation of Revenue Full definition →		1.05%	1.01%	1.22%	1.31%
Graham Net Nets Full definition →		(0.60)	(0.47)	(0.46)	(0.33)
Graham Number Full definition →		0.00	0.00	0.00	1.08
Earnings Yield Full definition →		0.20%	1.83%	3.14%	2.89%
Free Cash Flow Yield Full definition →		7.56%	5.77%	4.83%	(0.21%)
Revenue per Share Full definition →		2.50	2.60	2.29	2.49
Operating CF per Share Full definition →		0.38	0.42	(0.08)	(0.07)
Capex per Share Full definition →		(0.07)	(0.15)	(0.07)	(0.38)
Free Cash Flow per Share Full definition →		0.31	0.27	(0.15)	(0.45)
Cash per Share Full definition →		0.75	0.99	0.64	0.43
Shareholders Equity per Share Full definition →		(0.35)	(0.23)	(0.15)	0.10
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(0.35)	(0.23)	(0.15)	0.10
Free Cash Flow Full definition →		95.99	84.86	(48.45)	(143.99)
Working Capital Full definition →		976.37	1,029.55	1,069.86	1,063.84
Capital Expenditures Full definition →		(22.46)	(45.45)	(21.71)	(122.74)
Net Current Asset Value Full definition →		(1,871.35)	(1,838.43)	(1,788.28)	(1,796.29)
EV/EBIT Full definition →		15.32	15.76	14.59	17.76
Capex to Sales Full definition →		0.03	0.06	0.03	0.15
Price to Operating Income Full definition →		8.79	10.02	9.02	12.17
Other line items
Average Receivables Full definition →		821.56	835.91	803.05	915.01
Average Payables Full definition →		701.46	748.38	645.77	694.01
Average Inventory Full definition →		605.43	609.38	621.53	643.46
Average Assets Full definition →		3,530.43	3,589.86	3,452.73	3,599.57
Average Common Equity Full definition →		(101.76)	(90.42)	(88.98)	(39.75)

Show all line items

Columns are period end dates

Stockrow Weekly